[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Orexin Receptor Type 2-India Market Status and Trend Report 2013-2023

May 2018 | 156 pages | ID: OC9FC54D0FFMEN
MIReports Co., Limited

US$ 2,980.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Report Summary

Orexin Receptor Type 2-India Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Orexin Receptor Type 2 industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:

Whole India and Regional Market Size of Orexin Receptor Type 2 2013-2017, and development forecast 2018-2023
Main market players of Orexin Receptor Type 2 in India, with company and product introduction, position in the Orexin Receptor Type 2 market
Market status and development trend of Orexin Receptor Type 2 by types and applications
Cost and profit status of Orexin Receptor Type 2, and marketing status
Market growth drivers and challenges

The report segments the India Orexin Receptor Type 2 market as:

India Orexin Receptor Type 2 Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):

North India
Northeast India
East India
South India
West India

India Orexin Receptor Type 2 Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):

HTL-6641
MK-8133
Lemborexant
OPN-021
YNT-185
Others

India Orexin Receptor Type 2 Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)

Insomnia
Narcolepsy
Sleep Disorders
Major Depressive Disorder

India Orexin Receptor Type 2 Market: Players Segment Analysis (Company and Product introduction, Orexin Receptor Type 2 Sales Volume, Revenue, Price and Gross Margin):

Actelion Pharmaceuticals Ltd
Eisai Co Ltd
Evotec AG
Heptares Therapeutics Ltd
Idorsia Ltd
Johnson & Johnson
Merck & Co Inc
OptiNose US Inc
Yangtze River Pharmaceutical Group

In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OREXIN RECEPTOR TYPE

1.1 Definition of Orexin Receptor Type 2 in This Report
1.2 Commercial Types of Orexin Receptor Type
  1.2.1 HTL-6641
  1.2.2 MK-8133
  1.2.3 Lemborexant
  1.2.4 OPN-021
  1.2.5 YNT-185
  1.2.6 Others
1.3 Downstream Application of Orexin Receptor Type
  1.3.1 Insomnia
  1.3.2 Narcolepsy
  1.3.3 Sleep Disorders
  1.3.4 Major Depressive Disorder
1.4 Development History of Orexin Receptor Type
1.5 Market Status and Trend of Orexin Receptor Type 2 2013-2023
  1.5.1 United States Orexin Receptor Type 2 Market Status and Trend 2013-2023
  1.5.2 Regional Orexin Receptor Type 2 Market Status and Trend 2013-2023

CHAPTER 2 UNITED STATES MARKET STATUS AND FORECAST BY REGIONS

2.1 Market Status of Orexin Receptor Type 2 in United States 2013-2017
2.2 Consumption Market of Orexin Receptor Type 2 in United States by Regions
  2.2.1 Consumption Volume of Orexin Receptor Type 2 in United States by Regions
  2.2.2 Revenue of Orexin Receptor Type 2 in United States by Regions
2.3 Market Analysis of Orexin Receptor Type 2 in United States by Regions
  2.3.1 Market Analysis of Orexin Receptor Type 2 in New England 2013-2017
  2.3.2 Market Analysis of Orexin Receptor Type 2 in The Middle Atlantic 2013-2017
  2.3.3 Market Analysis of Orexin Receptor Type 2 in The Midwest 2013-2017
  2.3.4 Market Analysis of Orexin Receptor Type 2 in The West 2013-2017
  2.3.5 Market Analysis of Orexin Receptor Type 2 in The South 2013-2017
  2.3.6 Market Analysis of Orexin Receptor Type 2 in Southwest 2013-2017
2.4 Market Development Forecast of Orexin Receptor Type 2 in United States 2018-2023
  2.4.1 Market Development Forecast of Orexin Receptor Type 2 in United States 2018-2023
  2.4.2 Market Development Forecast of Orexin Receptor Type 2 by Regions 2018-2023

CHAPTER 3 UNITED STATES MARKET STATUS AND FORECAST BY TYPES

3.1 Whole United States Market Status by Types
  3.1.1 Consumption Volume of Orexin Receptor Type 2 in United States by Types
  3.1.2 Revenue of Orexin Receptor Type 2 in United States by Types
3.2 United States Market Status by Types in Major Countries
  3.2.1 Market Status by Types in New England
  3.2.2 Market Status by Types in The Middle Atlantic
  3.2.3 Market Status by Types in The Midwest
  3.2.4 Market Status by Types in The West
  3.2.5 Market Status by Types in The South
  3.2.6 Market Status by Types in Southwest
3.3 Market Forecast of Orexin Receptor Type 2 in United States by Types

CHAPTER 4 UNITED STATES MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY

4.1 Demand Volume of Orexin Receptor Type 2 in United States by Downstream Industry
4.2 Demand Volume of Orexin Receptor Type 2 by Downstream Industry in Major Countries
  4.2.1 Demand Volume of Orexin Receptor Type 2 by Downstream Industry in New England
  4.2.2 Demand Volume of Orexin Receptor Type 2 by Downstream Industry in The Middle Atlantic
  4.2.3 Demand Volume of Orexin Receptor Type 2 by Downstream Industry in The Midwest
  4.2.4 Demand Volume of Orexin Receptor Type 2 by Downstream Industry in The West
  4.2.5 Demand Volume of Orexin Receptor Type 2 by Downstream Industry in The South
  4.2.6 Demand Volume of Orexin Receptor Type 2 by Downstream Industry in Southwest
4.3 Market Forecast of Orexin Receptor Type 2 in United States by Downstream Industry

CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF OREXIN RECEPTOR TYPE

5.1 United States Economy Situation and Trend Overview
5.2 Orexin Receptor Type 2 Downstream Industry Situation and Trend Overview

CHAPTER 6 OREXIN RECEPTOR TYPE 2 MARKET COMPETITION STATUS BY MAJOR PLAYERS IN UNITED STATES

6.1 Sales Volume of Orexin Receptor Type 2 in United States by Major Players
6.2 Revenue of Orexin Receptor Type 2 in United States by Major Players
6.3 Basic Information of Orexin Receptor Type 2 by Major Players
  6.3.1 Headquarters Location and Established Time of Orexin Receptor Type 2 Major Players
  6.3.2 Employees and Revenue Level of Orexin Receptor Type 2 Major Players
6.4 Market Competition News and Trend
  6.4.1 Merger, Consolidation or Acquisition News
  6.4.2 Investment or Disinvestment News
  6.4.3 New Product Development and Launch

CHAPTER 7 OREXIN RECEPTOR TYPE 2 MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA

7.1 Actelion Pharmaceuticals Ltd
  7.1.1 Company profile
  7.1.2 Representative Orexin Receptor Type 2 Product
  7.1.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of Actelion Pharmaceuticals Ltd
7.2 Eisai Co Ltd
  7.2.1 Company profile
  7.2.2 Representative Orexin Receptor Type 2 Product
  7.2.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of Eisai Co Ltd
7.3 Evotec AG
  7.3.1 Company profile
  7.3.2 Representative Orexin Receptor Type 2 Product
  7.3.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of Evotec AG
7.4 Heptares Therapeutics Ltd
  7.4.1 Company profile
  7.4.2 Representative Orexin Receptor Type 2 Product
  7.4.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of Heptares Therapeutics Ltd
7.5 Idorsia Ltd
  7.5.1 Company profile
  7.5.2 Representative Orexin Receptor Type 2 Product
  7.5.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of Idorsia Ltd
7.6 Johnson & Johnson
  7.6.1 Company profile
  7.6.2 Representative Orexin Receptor Type 2 Product
  7.6.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of Johnson & Johnson
7.7 Merck & Co Inc
  7.7.1 Company profile
  7.7.2 Representative Orexin Receptor Type 2 Product
  7.7.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of Merck & Co Inc
7.8 OptiNose US Inc
  7.8.1 Company profile
  7.8.2 Representative Orexin Receptor Type 2 Product
  7.8.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of OptiNose US Inc
7.9 Yangtze River Pharmaceutical Group
  7.9.1 Company profile
  7.9.2 Representative Orexin Receptor Type 2 Product
  7.9.3 Orexin Receptor Type 2 Sales, Revenue, Price and Gross Margin of Yangtze River Pharmaceutical Group

CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OREXIN RECEPTOR TYPE

8.1 Industry Chain of Orexin Receptor Type
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis

CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF OREXIN RECEPTOR TYPE

9.1 Cost Structure Analysis of Orexin Receptor Type
9.2 Raw Materials Cost Analysis of Orexin Receptor Type
9.3 Labor Cost Analysis of Orexin Receptor Type
9.4 Manufacturing Expenses Analysis of Orexin Receptor Type

CHAPTER 10 MARKETING STATUS ANALYSIS OF OREXIN RECEPTOR TYPE

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

CHAPTER 11 REPORT CONCLUSION

CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE

12.1 Methodology/Research Approach
  12.1.1 Research Programs/Design
  12.1.2 Market Size Estimation
  12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
  12.2.1 Secondary Sources
  12.2.2 Primary Sources
12.3 Reference


More Publications